n-n-propyl-n-n-butyl-beta-dopamine has been researched along with Heart Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandon, TA; Fennell, WH; Ginos, JZ; Goldberg, LI; Mitchell, JR; Taylor, AA; Young, JB | 1 |
| Carey, RA; Jacob, L | 1 |
| Cohn, JN; Francis, GS | 1 |
2 review(s) available for n-n-propyl-n-n-butyl-beta-dopamine and Heart Failure
| Article | Year |
|---|---|
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
The autonomic nervous system in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Autonomic Nervous System; Benzodiazepines; Blood Vessels; Bromocriptine; Cardiovascular Agents; Catecholamines; Clonidine; Cricetinae; Dogs; Dopamine; Guanabenz; Heart; Heart Failure; Hemodynamics; Humans; Myocardium; Norepinephrine; Physical Exertion; Posture; Prognosis; Receptors, Adrenergic; Reflex; Stress, Physiological; Sympathetic Nervous System | 1986 |
1 other study(ies) available for n-n-propyl-n-n-butyl-beta-dopamine and Heart Failure
| Article | Year |
|---|---|
Propylbutyldopamine: hemodynamic effects in conscious dogs, normal human volunteers and patients with heart failure.
Topics: Adult; Aged; Animals; Blood Pressure; Dogs; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Renal Circulation; Sulpiride; Vascular Resistance | 1983 |